Issue 17 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

22

No.

17

April 26, 1996Apr 26, 1996

Free

DOWNLOAD THE PDF

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

Centers May Become More specialized, Klausner Tells AACI

NIH, NCI Being Discussions With HCFA On Reimbursement

Recent Issues

Volume 52 | Issue 41 - November 06, 2026

Volume 52 | Issue 40 - October 30, 2026

Volume 52 | Issue 39 - October 23, 2026

Volume 52 | Issue 38 - October 16, 2026

Volume 52 | Issue 37 - October 09, 2026

Volume 52 | Issue 36 - October 02, 2026